Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxyphenylalanine‐induced dyskinesia in Parkinsonian macaques-Reference-Cited by-同舟云学术

Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxyphenylalanine‐induced dyskinesia in Parkinsonian macaques

Published:2018-12-21 Issue:5 Volume:34 Page:708-716
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Johnston Tom H.¹²,Geva Michal³,Steiner Lilach⁴,Orbach Aric⁴,Papapetropoulos Spyros⁴,Savola Juha‐Matti⁵,Reynolds Ian J.⁶,Ravenscroft Paula¹²,Hill Michael¹²,Fox Susan H.⁷,Brotchie Jonathan M.¹²,Laufer Ralph⁸,Hayden Michael R.³

Affiliation:

1. Atuka Inc Toronto Ontario Canada

2. Krembil Research InstituteToronto Western Hospital, University Health Network Toronto Ontario Canada

3. Prilenia Therapeutics Development Ltd. (formerly 4) Herzliya Israel

4. Global Research and DevelopmentTeva Pharmaceutical Industries, Ltd. Netanya Israel

5. Teva Pharmaceuticals International, GmbH Basel Switzerland

6. Rewind TherapeuticsLeuven (formerly 4) Belgium

7. Movement Disorders Clinic, Toronto Western HospitalUniversity Health Network Toronto Ontario Canada

8. Lysogene S.A. (formerly 4) Neuilly sur Seine France

Publisher

Wiley

Subject